Tag Archives: Andrew Hard

Canna-Hub

Canna-Hub Now Accepting Lease Commitments Within Multi-Tenant Cannabis Zoned Facilities in Fresno County, California

Canna-Hub Now Accepting Lease Commitments Within Multi-Tenant Cannabis Zoned Facilities in Fresno County, California

SACRAMENTO, Calif., Feb. 20, 2018 /Weed Wire/ — Canna-Hub, a California-based real estate development and property management Company for the cannabis industry, today announced it is accepting lease commitments at a new 16-acre community in the city of Mendota, California.

Canna-Hub

Canna-Hub Now Accepting Lease Commitments Within First-of-its-Kind Cannabis Business Community in Williams, California

SACRAMENTO, Calif., Nov. 28, 2017 /Weed Wire/ — Canna-Hub, a California-based real estate development and property management Company for the cannabis industry, today announced it is accepting lease commitments at its first-of-its-kind cannabis business community in City of Williams, California, offering cannabis business operators the ability to lease space in newly constructed multi-tenant facilities designed specifically for cannabis operations.

Canna-Hub Announces Launch of California’s Largest, Most Sophisticated Cannabis Real Estate Portfolio to Help Business Owners Capture Green Rush

SACRAMENTO, Calif., Sept. 12, 2017 /Weed Wire/ — Canna-Hub, a California-based real estate development and property management Company for the cannabis industry, today announced its innovative cannabis real estate development business model to help current and prospective cannabis licensees secure properly zoned property for their cannabis businesses in California.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Announces State of Mexico’s Historic Purchase of Company’s Cannabis Product for Its Citizens

SAN DIEGO, Aug. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that the State of Mexico’s government has purchased the company’s Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil products from its subsidiary HempMeds Mexico® to treat 11 of its citizens suffering from varying indications including Refractory Epilepsy and Lennox Gastaut-Syndrome.

Axim Biotech - MedChew Rx

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.

CURE Pharmaceutical

CURE Pharmaceutical and CannaKids Announces Research Collaboration with Technion Israel Institute of Technology on Cancer-Fighting Cannabinoids

OXNARD, Calif., May 31, 2017 /Weed Wire/ — CURE Pharmaceutical (OTCQB: CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the company’s partnership with CannaKids has entered into a strategic research collaboration with Technion Research and Development Foundation Ltd., a wholly owned subsidiary of the Technion Israel Institute of Technology, in order to research how different cannabinoid compounds within cannabis strains can be used to treat various subtypes of cancer.

Americans for Safe Access Opioid Veterans Senate Committee

Cannabis Patients, Advocates, and Industry Leaders Converge at National Medical Cannabis Unity Conference in D.C.

WASHINGTON, March 28, 2017 /Weed Wire/ — Starting on Friday, April 7th and running until Tuesday, April 11th, medical cannabis industry business leaders, medical and legal professionals, advocates, and patients will gather at the Unity 2017 conference in Washington, D.C. to discuss common-sense policies and approaches to safe medical cannabis access and use. With the uncertainty of policies under a new U.S. administration, 2017 will be one of the most important years for medical cannabis policy ever.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol

SAN DIEGO, Calif., March 28, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB: AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API (Active Pharmaceutical Ingredient) production company to develop a dronabinol-based functional, controlled-release chewing gum product based on AXIM IP and technology.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

NEW YORK, March 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has retained the services of Ora®, Inc.,

SeeThruEquity RSHO Raúl Elizalde

Study Results: Medical Marijuana, Inc. Subsidiary HempMeds Mexico Announces Release of Study Using Its Real Scientific Hemp Oil-X to Treat Epileptic Children

SAN DIEGO, Calif., March 14, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico is holding a press conference in Mexico City, Mexico, today to reveal the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum

NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

SAN DIEGO, Calif., March 1, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by recent statements from Trump administration officials hinting at a crackdown on recreational marijuana.

SeeThruEquity RSHO Raúl Elizalde

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

SAN DIEGO, Calif., Feb. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat patients in the country suffering from Multiple Sclerosis.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana Inc. Subsidiary, HempMeds, Announces New Affiliate Program Showcasing Customer Loyalty

SAN DIEGO, Calif., Feb. 13, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is announcing a new affiliate program showcasing customer loyalty by allowing them to earn a commission by referring customers to the company.

SeeThruEquity RSHO Raúl Elizalde

Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., Feb., 7, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country suffering from Alzheimer’s disease.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Recognizes One-Year Anniversary of First RSHO-X™ Import Permit

SAN DIEGO, Jan. 31, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, is proud to announce the progress made by subsidiary HempMeds® Mexico upon the one-year anniversary of the first-ever import permit for RSHO-X™ into Mexico.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana Inc. Subsidiary Kannaway® Announces Launch of a New Product— “Kannaway® Gold Premium Hemp Oil”

SAN DIEGO, Jan. 25, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway® LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a new premium hemp oil product – Kannaway Gold.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

SAN DIEGO, Jan. 24, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s health authority COFEPRIS to import their flagship product Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a patient for their pain associated with cancer treatments and for their general well-being.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

SAN DIEGO, Jan. 13, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet Event in Atlanta, Ga., this weekend.

MJNA and AXIM

Medical Marijuana, Inc. Subsidiary, HempMeds(R) Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc.’s Investment Axim(R) Biotech Files IP Application on Proprietary Method to Extract High-Purity THC

SAN DIEGO, Nov. 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC PINK: AXIM) has filed an IP application with the World Intellectual Property Organization.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Subsidiary HempMeds(R) Mexico Begins Distribution of Flagship Product Real Scientific Hemp Oil(TM) to Colombian Market

SAN DIEGO, Calif., Nov. 28, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico, the first and only company with approval from COFEPRIS to legally import a cannabis product into Mexico, has begun distributing Real Scientific Hemp Oil™ (RSHO™) to Colombia.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc.’s Kannaway, LLC Launches Refresh of World-Renowned Brand at ‘Genesis’ Event in San Diego

SAN DIEGO, Calif., Nov. 21, 2016 /Weed Wire/ — Medical Marijuana, Inc. announced today that its portfolio company Kannaway launched a refresh of its world-renowned brand at its `Genesis: People, Purpose, Passion’ event in San Diego this November.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. and Subsidiary HempMeds Partner With CannaNative(TM) to Produce First-Ever Cannabis Product Line for Native American Marketplace

SAN DIEGO, Calif., Aug. 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) and its subsidiary HempMeds® announced today a partnership with CannaNative™, LLC (“CannaNative™”) to produce the first-ever cannabis product line for the Native American marketplace.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc.’s Subsidiary HempMeds(R) Mexico to Sponsor and Exhibit at Expoweed Conference in Mexico City

SAN DIEGO, Calif., Aug. 12, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico is sponsoring and exhibiting at the Aug. 12-14 ExpoWeed Conference, the first-ever cannabis conference to be held in Mexico.

SeeThruEquity RSHO Raúl Elizalde

Medical Cannabis Activist Raul Elizalde to Join Medical Marijuana, Inc. at Southern California Cannabis Conference and Expo

SAN DIEGO, Aug. 3, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that medical cannabis activist Raul Elizalde of Mexico will join Company representatives at the Southern California Cannabis Conference and Expo (SocalCCExpo) at the San Diego Convention Center to discuss his fight to unify the voices of families and patients in need of medical cannabis in Mexico.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Hires New Director of Human Resources to Support Company’s Rapid Growth, International Expansion

SAN DIEGO, Aug. 1, 2016/Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team today announced that Melissa Temple-Agosta has been hired as Director of Human Resources, reporting directly to Senior Vice President of Operations Blake Schroeder.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Now Hiring for Sales and Marketing Positions for Booming Cannabis Industry

SAN DIEGO, July 28, 2016 /Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team announced today that it’s currently hiring for open sales and marketing positions, as the Company continues its rapid expansion.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Portfolio Company Kannalife Featured in Sports Illustrated Article About Research That Could Be “Future New Wave of Medicine”

SAN DIEGO, Calif., July 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company Kannalife Sciences, Inc. was the focus of a Sports Illustrated online article about how the breakthrough cannabinoid research the Company is conducting could be the “future new wave of medicine” for traumatic brain injuries.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Receives New Permit to Export Into Paraguay, Plans New Latin America Expansion

SAN DIEGO, Calif., July 5, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that the Paraguay government has issued a new import permit for the Company’s flagship product Real Scientific Hemp Oil™ (RSHO™) for a new patient in the country.

MJNA and AXIM

Medical Marijuana, Inc. (MJNA) Appoints Blake N. Schroeder, Esq., As Vice President of Operations

SAN DIEGO, March 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) is proud to announce to shareholders and the public that the global industrial hemp investor and innovator has appointed Blake N. Schroeder, Esq., as Vice President of Operations at Medical Marijuana, Inc.

MJNA and AXIM

Brazil’s Government Health Agency Approves Patient’s Request for Medical Marijuana, Inc.’s RSHO™ for a New Indication: Parkinson’s Disease

SAN DIEGO,Nov. 18, 2015 /Weed Wire/ — Medical Marijuana, Inc. is pleased to announce to shareholders and to the public that its flagship product Real Scientific Hemp Oil™ (RSHO™) has been approved on a case-by-case basis for Parkinson’s disease by the Brazilian Government Health Agency ANVISA.

Axim Biotech - MedChew Rx

AXIM Biotech Announces Launch of Clinical Trials on MedChew RX™ and Development of Pharmaceutical-Grade Cannabis Chewing Gum

SAN DIEGO, Aug. 11, 2015 /Weed Wire/ — AXIM Biotechnologies, Inc. (OTC: AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products – all derived from industrial hemp.


Top